The Independent
UK · 1 hrs ago
✦ 78◉ Centre
New dual-action drug a ‘promising step forward’ for patients with hard-to-treat lung cancer
78Quality
0Ratings
0Comments
AI Analysis
Quality 78/100
Partisan intensity 25/100
ObjectivePartisan
◉ Centre ✓ Fair headline
Researchers have identified a new dual-action drug that experts say represents progress in treating advanced squamous non-small cell lung cancer, a difficult-to-treat form of the disease.
New dual-action drug a ‘promising step forward’ for patients with hard-to-treat lung cancer
Experts have described the findings as a ‘promising step forward‘ for patients with advanced squamous non-small cell lung cancer
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!